SOPHiA Genetics (NASDAQ: SOPH)
SOPHiA Genetics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
SOPHiA Genetics Company Info
SOPHiA GENETICS SA is a healthcare technology company, which engages in the practice of data driven medicine as the standard of care and for life sciences research. It operates through the following geographical segments: France, Italy, United States, Spain, Turkey, Austria, Brazil, United Kingdom, Switzerland, Germany, and Other. It is the creator of the SOPHiA DDM Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The company was founded by Jurgi Camblong, Pierre Hutter and Lars Steinmetz in 2011 and is headquartered in Saint Sulpice, Switzerland.
News & Analysis
No articles found.
Valuation
Earnings Transcripts
Sophia Genetics SA (SOPH) Q2 2022 Earnings Call Transcript
SOPH earnings call for the period ending June 30, 2022.
Sophia Genetics SA (SOPH) Q1 2022 Earnings Call Transcript
SOPH earnings call for the period ending March 31, 2022.
Sophia Genetics SA (SOPH) Q4 2021 Earnings Call Transcript
SOPH earnings call for the period ending December 31, 2021.
Sophia Genetics SA (SOPH) Q3 2021 Earnings Call Transcript
SOPH earnings call for the period ending September 30, 2021.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.